NexImmune's AIM ACT to be studied in Columbia University's PDO models of HPV-associated cancers April 27, 2022 No Comments
LYL-797, ROR1-targeted CAR T-cell candidate designed using reprogramming technologies April 27, 2022 No Comments
QL-401 shows improved blood safety and is efficacious against solid and hematologic cancers April 27, 2022 No Comments
NBL-028: a CLDN6-CD137 bispecific antibody for treating CLDN6-positive tumors April 27, 2022 No Comments
Portage, NCI and Stimunity collaborate to advance STING agonists and anti-RAGE agents April 26, 2022 No Comments
Turnstone Biologics collaborates with University of Montreal for development of TIL therapy April 26, 2022 No Comments
CLN-978, a next-generation CD19-targeted therapeutic for the treatment of B-cell malignancies April 25, 2022 No Comments
RSS